Presentation is loading. Please wait.

Presentation is loading. Please wait.

Optimal pharmacologic approach to patients with hypertriglyceridemia and low high- density lipoprotein-cholesterol: Randomized comparison of fenofibrate.

Similar presentations


Presentation on theme: "Optimal pharmacologic approach to patients with hypertriglyceridemia and low high- density lipoprotein-cholesterol: Randomized comparison of fenofibrate."— Presentation transcript:

1 Optimal pharmacologic approach to patients with hypertriglyceridemia and low high- density lipoprotein-cholesterol: Randomized comparison of fenofibrate 160mg and niacin 1500mg  Jin Wi, Jong-Youn Kim, Sungha Park, Seok-Min Kang, Yangsoo Jang, Namsik Chung, Won-Heum Shim, Seung-Yun Cho, Sang-Hak Lee  Atherosclerosis  Volume 213, Issue 1, Pages (November 2010) DOI: /j.atherosclerosis Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions

2 Fig. 1 Study profile showing the numbers of subjects who participated or dropped out at each step. Atherosclerosis  , DOI: ( /j.atherosclerosis ) Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions

3 Fig. 2 Bar graph showing the mean percent changes in apolipoproteins (left upper panel), TC, TG, HDL-C, LDL-C (left middle panel), Lp (a) (left lower panel), glucose, hemoglobin A1c (right upper panel), insulin, HOMA-IR (right middle panel), and hs-CRP (right lower panel) after drug treatment. * Median percent change. Atherosclerosis  , DOI: ( /j.atherosclerosis ) Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions


Download ppt "Optimal pharmacologic approach to patients with hypertriglyceridemia and low high- density lipoprotein-cholesterol: Randomized comparison of fenofibrate."

Similar presentations


Ads by Google